{"name":"AB2 Bio Ltd.","slug":"ab2-bio-ltd","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMisAJBVV95cUxPNGdPT3lScU1EUEpPRy00eDFfbnFtakJUZ2lFck5tWkdPX0lRcHR6SFlDSzVOQ0NualJVUWlEcUd3aTN3Q2xTaGFMcHFiZUJvSE8tS2tYOG14Z0xsMXRGeFVUYUx2MGxpaDhaWWVtS1R5YmdKT21qYWhjX0w4Tk4wNkRDTEJlbmpDRWNueExiMjg0UlFSOVhDZEU4cWF3UUp4SEU0UXZvWWpxaVZwQnFVTTVOLUZ1UTRQSFF3bF9PQU95NGdvV2U1WC02NUNfd2pZcGlKcEdIRHVoZTl4Vk1WY1pOZGJfWGdfeUlZQ20tQzZVTEl4NnF6UUcxdFVVZUZGUGRENklWOG4ybTFieXFGbDJJc0NFV1VYZlJuN1ZET2dwWUlDdzNsSXpBS1Y1WWll?oc=5","date":"2026-01-15","type":"pipeline","source":"prnewswire.com","summary":"Hemophagocytic Lymphohistiocytosis Market Poised for Phenomenal Expansion in the US at a CAGR of 24.5% During the Forecast Period (2025-2034) | DelveInsight - prnewswire.com","headline":"Hemophagocytic Lymphohistiocytosis Market Poised for Phenomenal Expansion in the US at a CAGR of 24.5% During the Foreca","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi9gFBVV95cUxPVDRBZWE1WGpTYV9uelFubmFDSWRUYUNRX29IQmVzQl9zdG5xMmVjV1JhTDBvamlvOV9WaFNkbGtSdDJ3aWZTcUlwZzhYMUhKXzJlRVA1QmxRQ0NSTjZlbC0xS29CNTlWaTBHUjc3cDJmVnFEdzVYSEFpZTBpblR1X3dRYk5saW5YT0Yyelk5bDlSWmVXQmRQQ0VidHEtWFY5X2l3cHNkTE83QWdlZWpoYTlObkhBbXNzcDFCYXJXUWVuTTlwZzN2QU04c1ZLQVRWUWZmZEZwckVGOXVIMlNDMlVEdHlPZ2RpelhoYnd5WHpPa1RrakE?oc=5","date":"2025-01-28","type":"deal","source":"BioPharma APAC","summary":"AB2 Bio and Nippon Shinyaku Forge U.S.-Japan Licensing Deal to Launch Tadekinig Alfa for Rare Hyperinflammatory Syndrome - BioPharma APAC","headline":"AB2 Bio and Nippon Shinyaku Forge U.S.-Japan Licensing Deal to Launch Tadekinig Alfa for Rare Hyperinflammatory Syndrome","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi8wFBVV95cUxQTGxQdzkwTFBlSHFxMFgyYmpRS0hUWWRYaG5VNWU2Sm4xSWtpalAzU19TNlh4Q3hyYXZyZG5QYWUzd2RHamY0M0doVGU4MTRId1JlTUpIRVU5bmVwUUoyNEJDWEhWdDNNanB6YU55eHJVZW84TG5nSVlZa3N5WHBxeHdjblh4R1ZaRDZ5UUZITFBFRjd0al9OaHNhMTNmeTBVdUE3cW9BQW1va1NMby1TX3RRdjAzUkt1eE9aLVlrQjItbGpuZkJ2d2Z3TEdrbE12VU1OLV9jNTFhLWtIeGZOUDIyNTRfRkFMX3hGX1FxcEw5Vms?oc=5","date":"2025-01-28","type":"pipeline","source":"BioSpectrum Asia","summary":"AB2 Bio signs licensing agreement worth $500 M with Nippon Shinyaku for ultra-rare autoimmune disease treatment - BioSpectrum Asia","headline":"AB2 Bio signs licensing agreement worth $500 M with Nippon Shinyaku for ultra-rare autoimmune disease treatment","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMingFBVV95cUxQNGY1Q280c1N4MmZELWRsdjh2dVRiTTduUzNwY1N5dGpnTFFOQ0w2TjlreURQZ3FRTG9Nck5ZTEJMb3hkNlhqbmxneUtqWDBORG1BeW95NzByTS1PNUh0ZHZkUVpVM25sdUFwem4yVndPRzV6UVJtUkpSY3kzbDRKODJUMXU2RWNFaXdXd2pPSVhwOTNiaUJHUUZJdlZOdw?oc=5","date":"2025-01-27","type":"pipeline","source":"startupticker.ch","summary":"AB2 Bio signs USD 600 million agreement with Nippon Shinyaku - startupticker.ch","headline":"AB2 Bio signs USD 600 million agreement with Nippon Shinyaku","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiowFBVV95cUxPR05LR3U2SG5tRXVHdHkxMGtQNjQ2eDVKVy1VSG5JeERVbEZTMEt1WDJGeW0zeFVmejNhclZ2ZFJGUXNCaF8tMHhuY2JFbDlFdDRjLWFGYi0tS1NiSXZUNVFla2pLZC1nWXhlREh1VW5IN1RGOGY1c1BFckRTQkl6bVhjTUk0UWd5TkFUbFdwUm1lZC1tc2xaS1dBMWZ0TUh6Wmxj?oc=5","date":"2024-06-21","type":"deal","source":"BioWorld News","summary":"Aprilbio, Evommune strike $475M deal for autoinflammatory drug - BioWorld News","headline":"Aprilbio, Evommune strike $475M deal for autoinflammatory drug","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijAFBVV95cUxOdXJIaWRYeGVFY1F0T1hmdlpXa1Y5V2lZdjVwSElDWUxvYzg2NVM5TFQxVTVDMzlNSHhrOGlWUnpERDdkdnpJdnduUGJ3TzNkWUJwTmhIYUNUX3E0TEZ0NkJjWTUyTkJmV0FBVS15YVZDT2hvb25Yb21zSHJpY1FyQThzWndxUzBFVkctaw?oc=5","date":"2023-03-08","type":"trial","source":"Clinical Trials Arena","summary":"AB2 Bio concludes subject enrolment in trial of Tadekinig alfa for HLH - Clinical Trials Arena","headline":"AB2 Bio concludes subject enrolment in trial of Tadekinig alfa for HLH","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivgFBVV95cUxPTFRSN25YT2FFdXRURmFabmtzYS1tWlNJTXljNWp4OGIxMGRNTXkzanJrQy1Ua2oyckQ2eEJDMjh5cktZNUdyaGxJOXpnVGFsQkpEQ2pITlNZXzlGS01Ya0FETzNCcTNRZ0tVT2hfSEtyQ1Jya29vQkVOSkE0c00wb3VNdDBFM1ZCcThuam5TWWhaSzU4MWNWck5QcWVqX3pjMXVJVDJUYkZuY2FJQ2M5YWFEWmVRbTZXTl9HTERn?oc=5","date":"2018-02-22","type":"pipeline","source":"European Pharmaceutical Review","summary":"IL-18 inhibitor drug holds great potential for inflammatory diseases - European Pharmaceutical Review","headline":"IL-18 inhibitor drug holds great potential for inflammatory diseases","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}